WHO ICTRP trial
PROJECT “¿SABES?”
PER-066-14 · Registro Peruano de Ensayos Clínicos (REPEC) · Recruiting
Key facts
| Trial ID | PER-066-14 |
|---|---|
| Public title | PROJECT “¿SABES?” |
| Scientific title | HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG MSM AND TRANSGENDER WOMEN IN LIMA, PERU |
| Primary sponsor | Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | IV |
| Countries | Peru |
| Conditions | -B24 Unspecified human immunodeficiency virus [HIV] disease Unspecified human immunodeficiency virus [HIV] disease;B24 ;Unspecified human immunodeficiency virus [HIV] disease |
| Interventions | Co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (STRIBILD®) or emtricitabine/tenofovir disoproxil fumarate/efavirenz (Atripla™). When STRIBILD and AtriplaTM are not available, co-formulated Truvada™… |
| Registration date | Mar 27, 2015 |
| Target size | 3200 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: